# VistaGen Therapeutics Inc. (VTGN) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $486,000 |
| 2024 | $1M |
| 2023 | -$227,000 |
| 2022 | $1M |
| 2021 | $1M |
| 2020 | — |
| 2018 | — |
| 2017 | $1M |
| 2016 | — |
| 2013 | $200,400 |
| 2012 | $1M |
| 2011 | $2M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2025-12-31 | $303,000 |
| 2025-09-30 | $258,000 |
| 2025-06-30 | $244,000 |
| 2024-12-31 | $234,000 |
| 2024-09-30 | $183,000 |
| 2024-06-30 | $84,000 |
| 2023-12-31 | $411,000 |
| 2023-09-30 | $278,000 |
| 2023-06-30 | $177,000 |
| 2022-06-30 | $310,100 |
| 2021-12-31 | $357,900 |
| 2021-09-30 | $358,000 |
| 2021-06-30 | $354,100 |
| 2020-12-31 | $313,600 |
| 2020-09-30 | $334,000 |
| 2020-06-30 | — |
| 2019-12-31 | — |
| 2019-09-30 | — |
| 2017-12-31 | — |
| 2016-12-31 | $1M |
| 2015-12-31 | — |
| 2012-06-30 | $200,400 |
| 2011-12-31 | $2,400 |
| 2011-09-30 | $316,300 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/VTGN/revenue)